December 12, 2021

Living well with Blood Cancer

Here is the link to the recent Leukaemia Foundation webinar focussing on wellness in people living with Blood Cancers. There are 3 speakers making it a long webinar (2.5 hours). Jane Fletcher (psychologist) and Julie Allen (physiotherapist) provide excellent advice about living well with a blood cancer. Leukaemia Foundation Webinar...

Continue Reading

October 26, 2021

Sotrovimab for COVID-19

Sotrovimab is now available for Central Coast patients with COVID-19 who are at high-risk of developing severe disease. This includes immunocompromised patients, whether or not they have been vaccinated. Sotrovimab works by binding to the spike protein on the outside of the COVID-19 virus. This is the same spike protein...

Continue Reading

October 10, 2021

Third Dose of COVID-19 Vaccinations for Immunocompromised People

ATAGI has recommended that immunocompromised patients, including people with an active haematological malignancy, receive a 3rd primary dose of a COVID-19 vaccine. This includes all patients with myelodysplasia, leukaemia (acute or chronic), myeloproliferative neoplasms, myeloma and lymphoma. A 3rd dose of an mRNA vaccine (e.g. Pfizer or Moderna) should be...

Continue Reading

August 21, 2021

CANVACCS Survey for COVID-19 Vaccinations

Dr Cecily Forsyth, Dr Richard Blennerhassett and Ms Jacqueline Jagger are actively involved with local and national research. In conjunction with Monash Health, we are interested to know your thoughts, opinions and experiences surrounding the COVID-19 vaccine. If you have previously, or are currently, receiving treatment for a haematologic condition...

Continue Reading